 | • レポートコード：MRC2Q12-18390 • 出版社/出版日：QYResearch / 2022年12月 • レポート形態：英文、PDF、113ページ • 納品方法：Eメール（納期：3営業日） • 産業分類：医療機器＆消耗品 |
| Single User | ￥725,200 (USD4,900) | ▷ お問い合わせ |
| Enterprise License | ￥1,450,400 (USD9,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 新型コロナウイルス感染症とロシア・ウクライナ戦争の影響により、全ゲノム重亜硫酸処理塩基配列決定のグローバル市場は 2022にxxxドルと推定され、2028年までにxxxドルの規模に達し、2022年から2028年の予測期間中にxxx%のCAGRで成長すると予測されています。 全ゲノム重亜硫酸処理塩基配列決定のアメリカ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 全ゲノム重亜硫酸処理塩基配列決定の中国市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 全ゲノム重亜硫酸処理塩基配列決定のヨーロッパ市場は、2023年から2028年の予測期間中にxxx%のCAGRで、2022年xxxドルから2028年xxxドルに達すると推定されています。 生産面において、本レポートは2017年から2022年までの全ゲノム重亜硫酸処理塩基配列決定の生産、成長率、メーカー別市場シェア、地域別市場シェア、および2028年までの予測を調査しています。販売面において、本レポートは2017年から2022年までの地域別、企業別、タイプ別、アプリケーション別の全ゲノム重亜硫酸処理塩基配列決定の売上および2028年までの予測に焦点を当てています。 全ゲノム重亜硫酸処理塩基配列決定のグローバル主要企業には、Illumina, Inc、Epigentek Group Inc、CD Genomics、Thermo Fisher Scientific, Inc、Novogene Co., Ltd、PerkinElmer, Inc、Promega Corporation、Nebula Genomics、Agilent Technologies、Qiagen、Macrogen Inc、Oxford Nanopore Technologies plc、Veritas、BGIなどがあります。2021年、世界のトップ5プレイヤーは売上ベースで約xxx％の市場シェアを占めています。 全ゲノム重亜硫酸処理塩基配列決定市場は、タイプとアプリケーションによって区分されます。世界の全ゲノム重亜硫酸処理塩基配列決定市場のプレーヤー、利害関係者、およびその他の参加者は、当レポートを有益なリソースとして使用することで優位に立つことができます。セグメント分析は、2017年～2028年期間のタイプ別およびアプリケーション別の販売量、売上、予測に焦点を当てています。 【タイプ別セグメント】 ヒト遺伝子検査、動物遺伝子検査 【アプリケーション別セグメント】 病気監視、法医学的鑑別、胎児検出、その他 【掲載地域】 北米：アメリカ、カナダ ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア アジア太平洋：日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア 中南米：メキシコ、ブラジル、アルゼンチン 中東・アフリカ：トルコ、サウジアラビア、UAE 【目次（一部）】 ・調査の範囲 - 全ゲノム重亜硫酸処理塩基配列決定製品概要 - タイプ別市場（ヒト遺伝子検査、動物遺伝子検査） - アプリケーション別市場（病気監視、法医学的鑑別、胎児検出、その他） - 調査の目的 ・エグゼクティブサマリー - 世界の全ゲノム重亜硫酸処理塩基配列決定販売量予測2017-2028 - 世界の全ゲノム重亜硫酸処理塩基配列決定売上予測2017-2028 - 全ゲノム重亜硫酸処理塩基配列決定の地域別販売量 - 全ゲノム重亜硫酸処理塩基配列決定の地域別売上 - 北米市場 - ヨーロッパ市場 - アジア太平洋市場 - 中南米市場 - 中東・アフリカ市場 ・メーカーの競争状況 - 主要メーカー別全ゲノム重亜硫酸処理塩基配列決定販売量 - 主要メーカー別全ゲノム重亜硫酸処理塩基配列決定売上 - 主要メーカー別全ゲノム重亜硫酸処理塩基配列決定価格 - 競争状況の分析 - 企業M&A動向 ・タイプ別市場規模（ヒト遺伝子検査、動物遺伝子検査） - 全ゲノム重亜硫酸処理塩基配列決定のタイプ別販売量 - 全ゲノム重亜硫酸処理塩基配列決定のタイプ別売上 - 全ゲノム重亜硫酸処理塩基配列決定のタイプ別価格 ・アプリケーション別市場規模（病気監視、法医学的鑑別、胎児検出、その他） - 全ゲノム重亜硫酸処理塩基配列決定のアプリケーション別販売量 - 全ゲノム重亜硫酸処理塩基配列決定のアプリケーション別売上 - 全ゲノム重亜硫酸処理塩基配列決定のアプリケーション別価格 ・北米市場 - 北米の全ゲノム重亜硫酸処理塩基配列決定市場規模（タイプ別、アプリケーション別） - 主要国別の全ゲノム重亜硫酸処理塩基配列決定市場規模（アメリカ、カナダ） ・ヨーロッパ市場 - ヨーロッパの全ゲノム重亜硫酸処理塩基配列決定市場規模（タイプ別、アプリケーション別） - 主要国別の全ゲノム重亜硫酸処理塩基配列決定市場規模（ドイツ、フランス、イギリス、イタリア、ロシア） ・アジア太平洋市場 - アジア太平洋の全ゲノム重亜硫酸処理塩基配列決定市場規模（タイプ別、アプリケーション別） - 主要国別の全ゲノム重亜硫酸処理塩基配列決定市場規模（日本、中国、韓国、インド、オーストラリア、台湾、インドネシア、タイ、マレーシア） ・中南米市場 - 中南米の全ゲノム重亜硫酸処理塩基配列決定市場規模（タイプ別、アプリケーション別） - 主要国別の全ゲノム重亜硫酸処理塩基配列決定市場規模（メキシコ、ブラジル、アルゼンチン） ・中東・アフリカ市場 - 中東・アフリカの全ゲノム重亜硫酸処理塩基配列決定市場規模（タイプ別、アプリケーション別） - 主要国別の全ゲノム重亜硫酸処理塩基配列決定市場規模（トルコ、サウジアラビア） ・企業情報 Illumina, Inc、Epigentek Group Inc、CD Genomics、Thermo Fisher Scientific, Inc、Novogene Co., Ltd、PerkinElmer, Inc、Promega Corporation、Nebula Genomics、Agilent Technologies、Qiagen、Macrogen Inc、Oxford Nanopore Technologies plc、Veritas、BGI ・産業チェーン及び販売チャネル分析 - 全ゲノム重亜硫酸処理塩基配列決定の産業チェーン分析 - 全ゲノム重亜硫酸処理塩基配列決定の原材料 - 全ゲノム重亜硫酸処理塩基配列決定の生産プロセス - 全ゲノム重亜硫酸処理塩基配列決定の販売及びマーケティング - 全ゲノム重亜硫酸処理塩基配列決定の主要顧客 ・マーケットドライバー、機会、課題、リスク要因分析 - 全ゲノム重亜硫酸処理塩基配列決定の産業動向 - 全ゲノム重亜硫酸処理塩基配列決定のマーケットドライバー - 全ゲノム重亜硫酸処理塩基配列決定の課題 - 全ゲノム重亜硫酸処理塩基配列決定の阻害要因 ・主な調査結果 |
Whole genome bisulfite sequencing is a technology to detect methylation of all chromosome DNA in cells or tissues. Based on the fact that bisulfite can deamination cytosine without methylation in DNA and convert it into uracil, while the methylated cytosine remains unchanged, PCR amplification of required fragments will convert all uracil into thymine, and then high-throughput sequencing of PCR products will be carried out. By analyzing the methylation difference between different samples, we can study the regulation of DNA methylation level on gene expression.
报错
笔记
Report Overview
Due to the COVID-19 pandemic and Russia-Ukraine War Influence, the global market for Product Name estimated at US$ million in the year 2022, is projected to reach a revised size of US$ million by 2028, growing at a CAGR of % during the forecast period 2022-2028.
The USA market for Whole Genome Bisulfite Sequencing is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The China market for Whole Genome Bisulfite Sequencing is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The Europe market for Whole Genome Bisulfite Sequencing is estimated to increase from $ million in 2022 to reach $ million by 2028, at a CAGR of % during the forecast period of 2023 through 2028.
The global key manufacturers of Whole Genome Bisulfite Sequencing include Illumina, Inc, Epigentek Group Inc, CD Genomics, Thermo Fisher Scientific, Inc, Novogene Co., Ltd, PerkinElmer, Inc, Promega Corporation, Nebula Genomics and Agilent Technologies, etc. In 2021, the global top five players had a share approximately % in terms of revenue.
Report Scope
This latest report researches the industry structure, sales, revenue, price and gross margin. Major producers’ production locations, market shares, industry ranking and profiles are presented. The primary and secondary research is done in order to access up-to-date government regulations, market information and industry data. Data were collected from the Whole Genome Bisulfite Sequencing manufacturers, distributors, end users, industry associations, governments’ industry bureaus, industry publications, industry experts, third party database, and our in-house databases.
This report also includes a discussion of the major players across each regional Whole Genome Bisulfite Sequencing market. Further, it explains the major drivers and regional dynamics of the global Whole Genome Bisulfite Sequencing market and current trends within the industry.
Key Companies Covered
In this section of the report, the researchers have done a comprehensive analysis of the prominent players operating and the strategies they are focusing on to combat the intense competition. Company profiles and market share analysis of the prominent players are also provided in this section. Additionally, the specialists have done an all-encompassing analysis of each player. They have also provided reliable sales, revenue, price, market share and rank data of the manufacturers for the period 2017-2022. With the assistance of this report, key players, stakeholders, and other participants will be able to stay abreast of the recent and upcoming developments in the business, further enabling them to make efficient choices. Mentioned below are the prime players taken into account in this research report:
Illumina, Inc
Epigentek Group Inc
CD Genomics
Thermo Fisher Scientific, Inc
Novogene Co., Ltd
PerkinElmer, Inc
Promega Corporation
Nebula Genomics
Agilent Technologies
Qiagen
Macrogen Inc
Oxford Nanopore Technologies plc
Veritas
BGI
Market Segments
This report has explored the key segments: by Type and by Application. The lucrativeness and growth potential have been looked into by the industry experts in this report. This report also provides sales, revenue and average price forecast data by type and by application segments based on sales, price, and value for the period 2017-2028.
Whole Genome Bisulfite Sequencing Segment by Type
Human Gene Testing
Animal Gene Testing
Whole Genome Bisulfite Sequencing Segment by Application
Disease Surveillance
Forensic Identification
Fetal Detection
Other
Key Regions & Countries
This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the value and sales data of each region and country for the period 2017-2028.
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Colombia
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
COVID-19 and Russia-Ukraine War Influence Analysis
The readers in the section will understand how the Whole Genome Bisulfite Sequencing market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management, export and import, and production. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.
Report Includes:
This report presents an overview of global market for Whole Genome Bisulfite Sequencing, sales, revenue and price. Analyses of the global market trends, with historic market revenue/sales data for 2017 – 2021, estimates for 2022, and projections of CAGR through 2028.
This report researches the key producers of Whole Genome Bisulfite Sequencing, also provides the sales of main regions and countries. Highlights of the upcoming market potential for Whole Genome Bisulfite Sequencing, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Whole Genome Bisulfite Sequencing sales, revenue, market share and industry ranking of main manufacturers, data from 2017 to 2022. Identification of the major stakeholders in the global Whole Genome Bisulfite Sequencing market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, sales, revenue, and price, from 2017 to 2028. Evaluation and forecast the market size for Whole Genome Bisulfite Sequencing sales, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Illumina, Inc, Epigentek Group Inc, CD Genomics, Thermo Fisher Scientific, Inc, Novogene Co., Ltd, PerkinElmer, Inc, Promega Corporation, Nebula Genomics and Agilent Technologies, etc.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Sales (consumption), revenue of Whole Genome Bisulfite Sequencing in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 3: Detailed analysis of Whole Genome Bisulfite Sequencing manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments according to product types, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments according to application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, sales and revenue for each segment.
Chapter 7: Europe by type, by application and by country, sales and revenue for each segment.
Chapter 8: Asia Pacific by type, by application and by country, sales and revenue for each segment.
Chapter 9: Latin America by type, by application and by country, sales and revenue for each segment.
Chapter 10: Middle East and Africa by type, by application and by country, sales and revenue for each segment.
Chapter 11: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Whole Genome Bisulfite Sequencing sales, revenue, price, gross margin, and recent development, etc.
Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.
Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 14: The main points and conclusions of the report.
1 Study Coverage
1.1 Whole Genome Bisulfite Sequencing Product Introduction
1.2 Market by Type
1.2.1 Global Whole Genome Bisulfite Sequencing Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Human Gene Testing
1.2.3 Animal Gene Testing
1.3 Market by Application
1.3.1 Global Whole Genome Bisulfite Sequencing Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Disease Surveillance
1.3.3 Forensic Identification
1.3.4 Fetal Detection
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Whole Genome Bisulfite Sequencing Sales Estimates and Forecasts 2017-2028
2.2 Global Whole Genome Bisulfite Sequencing Revenue Estimates and Forecasts 2017-2028
2.3 Global Whole Genome Bisulfite Sequencing Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Whole Genome Bisulfite Sequencing Sales by Region
2.4.1 Global Whole Genome Bisulfite Sequencing Sales by Region (2017-2022)
2.4.2 Global Sales Whole Genome Bisulfite Sequencing by Region (2023-2028)
2.5 Global Whole Genome Bisulfite Sequencing Revenue by Region
2.5.1 Global Whole Genome Bisulfite Sequencing Revenue by Region (2017-2022)
2.5.2 Global Whole Genome Bisulfite Sequencing Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Whole Genome Bisulfite Sequencing Sales by Manufacturers
3.1.1 Global Top Whole Genome Bisulfite Sequencing Manufacturers by Sales (2017-2022)
3.1.2 Global Whole Genome Bisulfite Sequencing Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Whole Genome Bisulfite Sequencing in 2021
3.2 Global Whole Genome Bisulfite Sequencing Revenue by Manufacturers
3.2.1 Global Whole Genome Bisulfite Sequencing Revenue by Manufacturers (2017-2022)
3.2.2 Global Whole Genome Bisulfite Sequencing Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Whole Genome Bisulfite Sequencing Revenue in 2021
3.3 Global Whole Genome Bisulfite Sequencing Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Whole Genome Bisulfite Sequencing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Whole Genome Bisulfite Sequencing Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Whole Genome Bisulfite Sequencing Sales by Type
4.1.1 Global Whole Genome Bisulfite Sequencing Historical Sales by Type (2017-2022)
4.1.2 Global Whole Genome Bisulfite Sequencing Forecasted Sales by Type (2023-2028)
4.1.3 Global Whole Genome Bisulfite Sequencing Sales Market Share by Type (2017-2028)
4.2 Global Whole Genome Bisulfite Sequencing Revenue by Type
4.2.1 Global Whole Genome Bisulfite Sequencing Historical Revenue by Type (2017-2022)
4.2.2 Global Whole Genome Bisulfite Sequencing Forecasted Revenue by Type (2023-2028)
4.2.3 Global Whole Genome Bisulfite Sequencing Revenue Market Share by Type (2017-2028)
4.3 Global Whole Genome Bisulfite Sequencing Price by Type
4.3.1 Global Whole Genome Bisulfite Sequencing Price by Type (2017-2022)
4.3.2 Global Whole Genome Bisulfite Sequencing Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Whole Genome Bisulfite Sequencing Sales by Application
5.1.1 Global Whole Genome Bisulfite Sequencing Historical Sales by Application (2017-2022)
5.1.2 Global Whole Genome Bisulfite Sequencing Forecasted Sales by Application (2023-2028)
5.1.3 Global Whole Genome Bisulfite Sequencing Sales Market Share by Application (2017-2028)
5.2 Global Whole Genome Bisulfite Sequencing Revenue by Application
5.2.1 Global Whole Genome Bisulfite Sequencing Historical Revenue by Application (2017-2022)
5.2.2 Global Whole Genome Bisulfite Sequencing Forecasted Revenue by Application (2023-2028)
5.2.3 Global Whole Genome Bisulfite Sequencing Revenue Market Share by Application (2017-2028)
5.3 Global Whole Genome Bisulfite Sequencing Price by Application
5.3.1 Global Whole Genome Bisulfite Sequencing Price by Application (2017-2022)
5.3.2 Global Whole Genome Bisulfite Sequencing Price Forecast by Application (2023-2028)
6 North America
6.1 North America Whole Genome Bisulfite Sequencing Market Size by Type
6.1.1 North America Whole Genome Bisulfite Sequencing Sales by Type (2017-2028)
6.1.2 North America Whole Genome Bisulfite Sequencing Revenue by Type (2017-2028)
6.2 North America Whole Genome Bisulfite Sequencing Market Size by Application
6.2.1 North America Whole Genome Bisulfite Sequencing Sales by Application (2017-2028)
6.2.2 North America Whole Genome Bisulfite Sequencing Revenue by Application (2017-2028)
6.3 North America Whole Genome Bisulfite Sequencing Market Size by Country
6.3.1 North America Whole Genome Bisulfite Sequencing Sales by Country (2017-2028)
6.3.2 North America Whole Genome Bisulfite Sequencing Revenue by Country (2017-2028)
6.3.3 United States
6.3.4 Canada
7 Europe
7.1 Europe Whole Genome Bisulfite Sequencing Market Size by Type
7.1.1 Europe Whole Genome Bisulfite Sequencing Sales by Type (2017-2028)
7.1.2 Europe Whole Genome Bisulfite Sequencing Revenue by Type (2017-2028)
7.2 Europe Whole Genome Bisulfite Sequencing Market Size by Application
7.2.1 Europe Whole Genome Bisulfite Sequencing Sales by Application (2017-2028)
7.2.2 Europe Whole Genome Bisulfite Sequencing Revenue by Application (2017-2028)
7.3 Europe Whole Genome Bisulfite Sequencing Market Size by Country
7.3.1 Europe Whole Genome Bisulfite Sequencing Sales by Country (2017-2028)
7.3.2 Europe Whole Genome Bisulfite Sequencing Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Whole Genome Bisulfite Sequencing Market Size by Type
8.1.1 Asia Pacific Whole Genome Bisulfite Sequencing Sales by Type (2017-2028)
8.1.2 Asia Pacific Whole Genome Bisulfite Sequencing Revenue by Type (2017-2028)
8.2 Asia Pacific Whole Genome Bisulfite Sequencing Market Size by Application
8.2.1 Asia Pacific Whole Genome Bisulfite Sequencing Sales by Application (2017-2028)
8.2.2 Asia Pacific Whole Genome Bisulfite Sequencing Revenue by Application (2017-2028)
8.3 Asia Pacific Whole Genome Bisulfite Sequencing Market Size by Region
8.3.1 Asia Pacific Whole Genome Bisulfite Sequencing Sales by Region (2017-2028)
8.3.2 Asia Pacific Whole Genome Bisulfite Sequencing Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 China Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
9 Latin America
9.1 Latin America Whole Genome Bisulfite Sequencing Market Size by Type
9.1.1 Latin America Whole Genome Bisulfite Sequencing Sales by Type (2017-2028)
9.1.2 Latin America Whole Genome Bisulfite Sequencing Revenue by Type (2017-2028)
9.2 Latin America Whole Genome Bisulfite Sequencing Market Size by Application
9.2.1 Latin America Whole Genome Bisulfite Sequencing Sales by Application (2017-2028)
9.2.2 Latin America Whole Genome Bisulfite Sequencing Revenue by Application (2017-2028)
9.3 Latin America Whole Genome Bisulfite Sequencing Market Size by Country
9.3.1 Latin America Whole Genome Bisulfite Sequencing Sales by Country (2017-2028)
9.3.2 Latin America Whole Genome Bisulfite Sequencing Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Whole Genome Bisulfite Sequencing Market Size by Type
10.1.1 Middle East and Africa Whole Genome Bisulfite Sequencing Sales by Type (2017-2028)
10.1.2 Middle East and Africa Whole Genome Bisulfite Sequencing Revenue by Type (2017-2028)
10.2 Middle East and Africa Whole Genome Bisulfite Sequencing Market Size by Application
10.2.1 Middle East and Africa Whole Genome Bisulfite Sequencing Sales by Application (2017-2028)
10.2.2 Middle East and Africa Whole Genome Bisulfite Sequencing Revenue by Application (2017-2028)
10.3 Middle East and Africa Whole Genome Bisulfite Sequencing Market Size by Country
10.3.1 Middle East and Africa Whole Genome Bisulfite Sequencing Sales by Country (2017-2028)
10.3.2 Middle East and Africa Whole Genome Bisulfite Sequencing Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Illumina, Inc
11.1.1 Illumina, Inc Corporation Information
11.1.2 Illumina, Inc Overview
11.1.3 Illumina, Inc Whole Genome Bisulfite Sequencing Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Illumina, Inc Whole Genome Bisulfite Sequencing Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Illumina, Inc Recent Developments
11.2 Epigentek Group Inc
11.2.1 Epigentek Group Inc Corporation Information
11.2.2 Epigentek Group Inc Overview
11.2.3 Epigentek Group Inc Whole Genome Bisulfite Sequencing Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Epigentek Group Inc Whole Genome Bisulfite Sequencing Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Epigentek Group Inc Recent Developments
11.3 CD Genomics
11.3.1 CD Genomics Corporation Information
11.3.2 CD Genomics Overview
11.3.3 CD Genomics Whole Genome Bisulfite Sequencing Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 CD Genomics Whole Genome Bisulfite Sequencing Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 CD Genomics Recent Developments
11.4 Thermo Fisher Scientific, Inc
11.4.1 Thermo Fisher Scientific, Inc Corporation Information
11.4.2 Thermo Fisher Scientific, Inc Overview
11.4.3 Thermo Fisher Scientific, Inc Whole Genome Bisulfite Sequencing Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Thermo Fisher Scientific, Inc Whole Genome Bisulfite Sequencing Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Thermo Fisher Scientific, Inc Recent Developments
11.5 Novogene Co., Ltd
11.5.1 Novogene Co., Ltd Corporation Information
11.5.2 Novogene Co., Ltd Overview
11.5.3 Novogene Co., Ltd Whole Genome Bisulfite Sequencing Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 Novogene Co., Ltd Whole Genome Bisulfite Sequencing Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 Novogene Co., Ltd Recent Developments
11.6 PerkinElmer, Inc
11.6.1 PerkinElmer, Inc Corporation Information
11.6.2 PerkinElmer, Inc Overview
11.6.3 PerkinElmer, Inc Whole Genome Bisulfite Sequencing Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 PerkinElmer, Inc Whole Genome Bisulfite Sequencing Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 PerkinElmer, Inc Recent Developments
11.7 Promega Corporation
11.7.1 Promega Corporation Corporation Information
11.7.2 Promega Corporation Overview
11.7.3 Promega Corporation Whole Genome Bisulfite Sequencing Sales, Price, Revenue and Gross Margin (2017-2022)
11.7.4 Promega Corporation Whole Genome Bisulfite Sequencing Product Model Numbers, Pictures, Descriptions and Specifications
11.7.5 Promega Corporation Recent Developments
11.8 Nebula Genomics
11.8.1 Nebula Genomics Corporation Information
11.8.2 Nebula Genomics Overview
11.8.3 Nebula Genomics Whole Genome Bisulfite Sequencing Sales, Price, Revenue and Gross Margin (2017-2022)
11.8.4 Nebula Genomics Whole Genome Bisulfite Sequencing Product Model Numbers, Pictures, Descriptions and Specifications
11.8.5 Nebula Genomics Recent Developments
11.9 Agilent Technologies
11.9.1 Agilent Technologies Corporation Information
11.9.2 Agilent Technologies Overview
11.9.3 Agilent Technologies Whole Genome Bisulfite Sequencing Sales, Price, Revenue and Gross Margin (2017-2022)
11.9.4 Agilent Technologies Whole Genome Bisulfite Sequencing Product Model Numbers, Pictures, Descriptions and Specifications
11.9.5 Agilent Technologies Recent Developments
11.10 Qiagen
11.10.1 Qiagen Corporation Information
11.10.2 Qiagen Overview
11.10.3 Qiagen Whole Genome Bisulfite Sequencing Sales, Price, Revenue and Gross Margin (2017-2022)
11.10.4 Qiagen Whole Genome Bisulfite Sequencing Product Model Numbers, Pictures, Descriptions and Specifications
11.10.5 Qiagen Recent Developments
11.11 Macrogen Inc
11.11.1 Macrogen Inc Corporation Information
11.11.2 Macrogen Inc Overview
11.11.3 Macrogen Inc Whole Genome Bisulfite Sequencing Sales, Price, Revenue and Gross Margin (2017-2022)
11.11.4 Macrogen Inc Whole Genome Bisulfite Sequencing Product Model Numbers, Pictures, Descriptions and Specifications
11.11.5 Macrogen Inc Recent Developments
11.12 Oxford Nanopore Technologies plc
11.12.1 Oxford Nanopore Technologies plc Corporation Information
11.12.2 Oxford Nanopore Technologies plc Overview
11.12.3 Oxford Nanopore Technologies plc Whole Genome Bisulfite Sequencing Sales, Price, Revenue and Gross Margin (2017-2022)
11.12.4 Oxford Nanopore Technologies plc Whole Genome Bisulfite Sequencing Product Model Numbers, Pictures, Descriptions and Specifications
11.12.5 Oxford Nanopore Technologies plc Recent Developments
11.13 Veritas
11.13.1 Veritas Corporation Information
11.13.2 Veritas Overview
11.13.3 Veritas Whole Genome Bisulfite Sequencing Sales, Price, Revenue and Gross Margin (2017-2022)
11.13.4 Veritas Whole Genome Bisulfite Sequencing Product Model Numbers, Pictures, Descriptions and Specifications
11.13.5 Veritas Recent Developments
11.14 BGI
11.14.1 BGI Corporation Information
11.14.2 BGI Overview
11.14.3 BGI Whole Genome Bisulfite Sequencing Sales, Price, Revenue and Gross Margin (2017-2022)
11.14.4 BGI Whole Genome Bisulfite Sequencing Product Model Numbers, Pictures, Descriptions and Specifications
11.14.5 BGI Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Whole Genome Bisulfite Sequencing Industry Chain Analysis
12.2 Whole Genome Bisulfite Sequencing Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Whole Genome Bisulfite Sequencing Production Mode & Process
12.4 Whole Genome Bisulfite Sequencing Sales and Marketing
12.4.1 Whole Genome Bisulfite Sequencing Sales Channels
12.4.2 Whole Genome Bisulfite Sequencing Distributors
12.5 Whole Genome Bisulfite Sequencing Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Whole Genome Bisulfite Sequencing Industry Trends
13.2 Whole Genome Bisulfite Sequencing Market Drivers
13.3 Whole Genome Bisulfite Sequencing Market Challenges
13.4 Whole Genome Bisulfite Sequencing Market Restraints
14 Key Findings in The Global Whole Genome Bisulfite Sequencing Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer